<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39338357</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1424-8247</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Pharmaceuticals (Basel, Switzerland)</Title><ISOAbbreviation>Pharmaceuticals (Basel)</ISOAbbreviation></Journal><ArticleTitle>Application of Mammalian Nudix Enzymes to Capped RNA Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1195</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ph17091195</ELocationID><Abstract><AbstractText>Following the success of mRNA vaccines against COVID-19, mRNA-based therapeutics have now become a great interest and potential. The development of this approach has been preceded by studies of modifications found on mRNA ribonucleotides that influence the stability, translation and immunogenicity of this molecule. The 5' cap of eukaryotic mRNA plays a critical role in these cellular functions and is thus the focus of intensive chemical modifications to affect the biological properties of in vitro-prepared mRNA. Enzymatic removal of the 5' cap affects the stability of mRNA in vivo. The NUDIX hydrolase Dcp2 was identified as the first eukaryotic decapping enzyme and is routinely used to analyse the synthetic cap at the 5' end of RNA. Here we highlight three additional NUDIX enzymes with known decapping activity, namely Nudt2, Nudt12 and Nudt16. These enzymes possess a different and some overlapping activity towards numerous 5' RNA cap structures, including non-canonical and chemically modified ones. Therefore, they appear as potent tools for comprehensive in vitro characterisation of capped RNA transcripts, with special focus on synthetic RNAs with therapeutic activity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lukaszewicz</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biophysics, Faculty of Physics, University of Warsaw, Pasteura 5, 02-093 Warsaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pharmaceuticals (Basel)</MedlineTA><NlmUniqueID>101238453</NlmUniqueID><ISSNLinking>1424-8247</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NUDIX family</Keyword><Keyword MajorTopicYN="N">Nudt12</Keyword><Keyword MajorTopicYN="N">Nudt16</Keyword><Keyword MajorTopicYN="N">Nudt2</Keyword><Keyword MajorTopicYN="N">Nudt5</Keyword><Keyword MajorTopicYN="N">mRNA cap</Keyword><Keyword MajorTopicYN="N">mRNA therapeutics</Keyword><Keyword MajorTopicYN="N">synthetic cap analogues</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39338357</ArticleId><ArticleId IdType="pmc">PMC11434898</ArticleId><ArticleId IdType="doi">10.3390/ph17091195</ArticleId><ArticleId IdType="pii">ph17091195</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sahin U., Muik A., Derhovanessian E., Vogler I., Kranz L.M., Vormehr M., Baum A., Pascal K., Quandt J., Maurus D., et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T-cell responses. Nature. 2020;586:594–599. doi: 10.1038/s41586-020-2814-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2814-7</ArticleId><ArticleId IdType="pubmed">32998157</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbett K.S., Edwards D.K., Leist S.R., Abiona O.M., Boyoglu-Barnum S., Gillespie R.A., Himansu S., Schäfer A., Ziwawo C.T., DiPiazza A.T., et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020;586:567–571. doi: 10.1038/s41586-020-2622-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2622-0</ArticleId><ArticleId IdType="pmc">PMC7581537</ArticleId><ArticleId IdType="pubmed">32756549</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:1465–1468. doi: 10.1126/science.1690918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1690918</ArticleId><ArticleId IdType="pubmed">1690918</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin U., Karikó K., Türeci Ö. mRNA-based therapeutics—Developing a new class of drugs. Nat. Rev. Drug Discov. 2014;13:759–780. doi: 10.1038/nrd4278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd4278</ArticleId><ArticleId IdType="pubmed">25233993</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikó K., Buckstein M., Ni H., Weissman D. Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Immunity. 2005;23:165–175. doi: 10.1016/j.immuni.2005.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2005.06.008</ArticleId><ArticleId IdType="pubmed">16111635</ArticleId></ArticleIdList></Reference><Reference><Citation>Aygün I., Barciszewski J. The forerunners and successful partnerships behind the BioNTech mRNA vaccine. J. Appl. Genet. 2023;65:47–55. doi: 10.1007/s13353-023-00793-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13353-023-00793-5</ArticleId><ArticleId IdType="pmc">PMC10789661</ArticleId><ArticleId IdType="pubmed">37861886</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Chai P., Jia R., Fan X. Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation. Mol. Cancer. 2020;19:1–17. doi: 10.1186/s12943-020-01194-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-020-01194-6</ArticleId><ArticleId IdType="pmc">PMC7164178</ArticleId><ArticleId IdType="pubmed">32303268</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuichi Y. Discovery of m7G-cap in eukaryotic mRNAs. Proc. Jpn. Acad. Ser. B. 2015;91:394–409. doi: 10.2183/pjab.91.394.</Citation><ArticleIdList><ArticleId IdType="doi">10.2183/pjab.91.394</ArticleId><ArticleId IdType="pmc">PMC4729855</ArticleId><ArticleId IdType="pubmed">26460318</ArticleId></ArticleIdList></Reference><Reference><Citation>Warminski M., Mamot A., Depaix A., Kowalska J., Jemielity J. Chemical Modifications of mRNA Ends for Therapeutic Applications. Accounts Chem. Res. 2023;56:2814–2826. doi: 10.1021/acs.accounts.3c00442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.accounts.3c00442</ArticleId><ArticleId IdType="pmc">PMC10586375</ArticleId><ArticleId IdType="pubmed">37782471</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurpiejewski K., Jankowska-Anyszka M., Grzela R. N2 modified cap analogues as translation inhibitors and substrates for preparation of therapeutic mRNA. Eur. Biophys. J. 2023;52:511–519. doi: 10.1007/s00249-023-01676-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00249-023-01676-7</ArticleId><ArticleId IdType="pmc">PMC10618310</ArticleId><ArticleId IdType="pubmed">37656232</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunckley T., Parker R. The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J. 1999;18:5411–5422. doi: 10.1093/emboj/18.19.5411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.19.5411</ArticleId><ArticleId IdType="pmc">PMC1171610</ArticleId><ArticleId IdType="pubmed">10508173</ArticleId></ArticleIdList></Reference><Reference><Citation>Lykke-Andersen J. Identification of a Human Decapping Complex Associated with hUpf Proteins in Nonsense-Mediated Decay. Mol. Cell. Biol. 2002;22:8114–8121. doi: 10.1128/MCB.22.23.8114-8121.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.23.8114-8121.2002</ArticleId><ArticleId IdType="pmc">PMC134073</ArticleId><ArticleId IdType="pubmed">12417715</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk E., Cougot N., Meyer S., Babajko S., Wahle E., Séraphin B. Human Dcp2: A catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 2002;21:6915–6924. doi: 10.1093/emboj/cdf678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/cdf678</ArticleId><ArticleId IdType="pmc">PMC139098</ArticleId><ArticleId IdType="pubmed">12486012</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Jiao X., Carr-Schmid A., Kiledjian M. The hDcp2 protein is a mammalian mRNA decapping enzyme. Proc. Natl. Acad. Sci. USA. 2002;99:12663–12668. doi: 10.1073/pnas.192445599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.192445599</ArticleId><ArticleId IdType="pmc">PMC130517</ArticleId><ArticleId IdType="pubmed">12218187</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh T., Peterson B., Tomasevic N., Peculis B.A. Xenopus U8 snoRNA Binding Protein Is a Conserved Nuclear Decapping Enzyme. Mol. Cell. 2004;13:817–828. doi: 10.1016/S1097-2765(04)00127-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(04)00127-3</ArticleId><ArticleId IdType="pubmed">15053875</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K.D., Jaffrey S.R. The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat. Rev. Mol. Cell Biol. 2014;15:313–326. doi: 10.1038/nrm3785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3785</ArticleId><ArticleId IdType="pmc">PMC4393108</ArticleId><ArticleId IdType="pubmed">24713629</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamudio J.R., Mittra B., Zeiner G.M., Feder M., Bujnicki J.M., Sturm N.R., Campbell D.A. Complete Cap 4 Formation Is Not Required for Viability in Trypanosoma brucei. Eukaryot. Cell. 2006;5:905–915. doi: 10.1128/EC.00080-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/EC.00080-06</ArticleId><ArticleId IdType="pmc">PMC1489268</ArticleId><ArticleId IdType="pubmed">16757738</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa M., Murai R., Hagiwara H., Hoshino T., Suyama K. Preparation of eukaryotic mRNA having differently methylated adenosine at the 5′-terminus and the effect of the methyl group in translation. Nucleic Acids Symp. Ser. 2009;53:129–130. doi: 10.1093/nass/nrp065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nass/nrp065</ArticleId><ArticleId IdType="pubmed">19749294</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauer J., Luo X., Blanjoie A., Jiao X., Grozhik A.V., Patil D.P., Linder B., Pickering B.F., Vasseur J.-J., Chen Q., et al. Reversible methylation of m6Am in the 5′ cap controls mRNA stability. Nature. 2017;541:371–375. doi: 10.1038/nature21022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21022</ArticleId><ArticleId IdType="pmc">PMC5513158</ArticleId><ArticleId IdType="pubmed">28002401</ArticleId></ArticleIdList></Reference><Reference><Citation>Warminski M., Sikorski P.J., Kowalska J., Jemielity J. Applications of Phosphate Modification and Labeling to Study (m)RNA Caps. Top. Curr. Chem. 2017;375:1–29. doi: 10.1007/s41061-017-0106-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41061-017-0106-y</ArticleId><ArticleId IdType="pmc">PMC5396385</ArticleId><ArticleId IdType="pubmed">28116583</ArticleId></ArticleIdList></Reference><Reference><Citation>Xhemalce B., Robson S.C., Kouzarides T. Human RNA Methyltransferase BCDIN3D Regulates MicroRNA Processing. Cell. 2012;151:278–288. doi: 10.1016/j.cell.2012.08.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.08.041</ArticleId><ArticleId IdType="pmc">PMC3640255</ArticleId><ArticleId IdType="pubmed">23063121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurth L., Gribling-Burrer A.-S., Verheggen C., Leichter M., Takeuchi A., Baudrey S., Martin F., Krol A., Bertrand E., Allmang C. Hypermethylated-capped selenoprotein mRNAs in mammals. Nucleic Acids Res. 2014;42:8663–8677. doi: 10.1093/nar/gku580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku580</ArticleId><ArticleId IdType="pmc">PMC4117793</ArticleId><ArticleId IdType="pubmed">25013170</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh G., Fritz S.E., Seufzer B., Boris-Lawrie K. The mRNA encoding the JUND tumor suppressor detains nuclear RNA-binding proteins to assemble polysomes that are unaffected by mTOR. J. Biol. Chem. 2020;295:7763–7773. doi: 10.1074/jbc.RA119.012005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.012005</ArticleId><ArticleId IdType="pmc">PMC7261793</ArticleId><ArticleId IdType="pubmed">32312751</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucko D., Boris-Lawrie K. Blocking tri-methylguanosine synthase 1 (TGS1) stops anchorage-independent growth of canine sarcomas. Cancer Gene Ther. 2023;30:1274–1284. doi: 10.1038/s41417-023-00636-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41417-023-00636-9</ArticleId><ArticleId IdType="pmc">PMC10501901</ArticleId><ArticleId IdType="pubmed">37386121</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohira T., Suzuki T. Precursors of tRNAs are stabilized by methylguanosine cap structures. Nat. Chem. Biol. 2016;12:648–655. doi: 10.1038/nchembio.2117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.2117</ArticleId><ArticleId IdType="pubmed">27348091</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhamid R.F., Plessy C., Yamauchi Y., Taoka M., de Hoon M., Gingeras T.R., Isobe T., Carninci P. Multiplicity of 5′ Cap Structures Present on Short RNAs. PLoS ONE. 2014;9:e102895. doi: 10.1371/journal.pone.0102895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0102895</ArticleId><ArticleId IdType="pmc">PMC4117478</ArticleId><ArticleId IdType="pubmed">25079783</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattay J. Noncanonical metabolite RNA caps: Classification, quantification, (de)capping, and function. Wiley Interdiscip. Rev. RNA. 2022;13:e1730. doi: 10.1002/wrna.1730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1730</ArticleId><ArticleId IdType="pubmed">35675554</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters R.W., Matheny T., Mizoue L.S., Rao B.S., Muhlrad D., Parker R. Identification of NAD + capped mRNAs in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 2016;114:480–485. doi: 10.1073/pnas.1619369114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1619369114</ArticleId><ArticleId IdType="pmc">PMC5255579</ArticleId><ArticleId IdType="pubmed">28031484</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao X., Doamekpor S.K., Bird J.G., Nickels B.E., Tong L., Hart R.P., Kiledjian M. 5′ End Nicotinamide Adenine Dinucleotide Cap in Human Cells Promotes RNA Decay through DXO-Mediated deNADding. Cell. 2017;168:1015–1027.e10. doi: 10.1016/j.cell.2017.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.02.019</ArticleId><ArticleId IdType="pmc">PMC5371429</ArticleId><ArticleId IdType="pubmed">28283058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiledjian M. Eukaryotic RNA 5′-End NAD + Capping and DeNADding. Trends Cell Biol. 2018;28:454–464. doi: 10.1016/j.tcb.2018.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2018.02.005</ArticleId><ArticleId IdType="pmc">PMC5962413</ArticleId><ArticleId IdType="pubmed">29544676</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermannová J., Julius C., Yuzenkova Y. The expanding field of non-canonical RNA capping: New enzymes and mechanisms. R. Soc. Open Sci. 2021;8 doi: 10.1098/rsos.201979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.201979</ArticleId><ArticleId IdType="pmc">PMC8131947</ArticleId><ArticleId IdType="pubmed">34017598</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao X., Zhang H., Zhu Z., Ji F., He Z., Yang Z., Xia Y., Cai Z. DpCoA tagSeq: Barcoding dpCoA-Capped RNA for Direct Nanopore Sequencing via Maleimide-Thiol Reaction. Anal. Chem. 2023;95:11124–11131. doi: 10.1021/acs.analchem.3c02063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.3c02063</ArticleId><ArticleId IdType="pmc">PMC10372868</ArticleId><ArticleId IdType="pubmed">37439785</ArticleId></ArticleIdList></Reference><Reference><Citation>Potužník J.F., Nešuta O., Škríba A., Voleníková B., Mititelu M., Mancini F., Serianni V., Fernandez H., Spustová K., Trylčová J., et al. Diadenosine Tetraphosphate (Ap4A) Serves as a 5′ RNA Cap in Mammalian Cells. Angew. Chem. Int. Ed. 2023;63:e202314951. doi: 10.1002/anie.202314951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202314951</ArticleId><ArticleId IdType="pubmed">37934413</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez I., Hayes K.E., Barr J.A., Harold A.D., Xie M., Bukhari S.I.A., Vasudevan S., Steitz J.A., DiMaio D. An Ex-portin-1-dependent microRNA biogenesis pathway during human cell quiescence. Proc. Natl. Acad. Sci. USA. 2017;114:E4961–E4970. doi: 10.1073/pnas.1618732114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1618732114</ArticleId><ArticleId IdType="pmc">PMC5488920</ArticleId><ArticleId IdType="pubmed">28584122</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R., Reddy R. Gamma-monomethyl phosphate: A cap structure in spliceosomal U6 small nuclear RNA. Proc. Natl. Acad. Sci. USA. 1989;86:8280–8283. doi: 10.1073/pnas.86.21.8280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.86.21.8280</ArticleId><ArticleId IdType="pmc">PMC298264</ArticleId><ArticleId IdType="pubmed">2813391</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Busch R.K., Singh R., Reddy R. Characterization of U6 small nuclear RNA cap-specific antibodies. Identification of gamma-monomethyl-GTP cap structure in 7SK and several other human small RNAs. J. Biol. Chem. 1990;265:19137–19142. doi: 10.1016/S0021-9258(17)30635-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)30635-X</ArticleId><ArticleId IdType="pubmed">2229067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Chew B.L.A., Lai Y., Dong H., Xu L., Balamkundu S., Cai W.M., Cui L., Liu C.F., Fu X.-Y., et al. Quantifying the RNA cap epitranscriptome reveals novel caps in cellular and viral RNA. Nucleic Acids Res. 2019;47:e130. doi: 10.1093/nar/gkz751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz751</ArticleId><ArticleId IdType="pmc">PMC6847653</ArticleId><ArticleId IdType="pubmed">31504804</ArticleId></ArticleIdList></Reference><Reference><Citation>Grudzien-Nogalska E., Stepinski J., Jemielity J., Zuberek J., Stolarski R., Rhoads R.E., Darzynkiewicz E. Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability. Methods Enzymol. 2007;431:203–227. doi: 10.1016/S0076-6879(07)31011-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0076-6879(07)31011-2</ArticleId><ArticleId IdType="pubmed">17923237</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Jia Y., Jacobson B., McCauley J., Kratzke R., Bitterman P.B., Wagner C.R. Treatment of Breast and Lung Cancer Cells with a N-7 Benzyl Guanosine Monophosphate Tryptamine Phosphoramidate Pronucleotide (4Ei-1) Results in Chemosensitization to Gemcitabine and Induced eIF4E Proteasomal Degradation. Mol. Pharm. 2013;10:523–531. doi: 10.1021/mp300699d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/mp300699d</ArticleId><ArticleId IdType="pmc">PMC5920544</ArticleId><ArticleId IdType="pubmed">23289910</ArticleId></ArticleIdList></Reference><Reference><Citation>Golojuch S., Kopcial M., Strzelecka D., Kasprzyk R., Baran N., Sikorski P.J., Kowalska J., Jemielity J. Exploring tryptamine conjugates as pronucleotides of phosphate-modified 7-methylguanine nucleotides targeting cap-dependent transla-tion. Bioorganic Med. Chem. 2020;28:115523. doi: 10.1016/j.bmc.2020.115523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2020.115523</ArticleId><ArticleId IdType="pubmed">32362385</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurpiejewski K., Piecyk K., Lukaszewicz M., Kamel K., Chmurski K., Kmiecik S., Jankowska-Anyszka M. The Synergistic Effect of N2 and N7 Modifications on the Inhibitory Efficacy of mRNA Cap Analogues. Pharmaceuticals. 2024;17:632. doi: 10.3390/ph17050632.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph17050632</ArticleId><ArticleId IdType="pmc">PMC11123931</ArticleId><ArticleId IdType="pubmed">38794202</ArticleId></ArticleIdList></Reference><Reference><Citation>Konarska M.M., Padgett R.A., Sharp P.A. Recognition of cap structure in splicing in vitro of mRNA precursors. Cell. 1984;38:731–736. doi: 10.1016/0092-8674(84)90268-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(84)90268-X</ArticleId><ArticleId IdType="pubmed">6567484</ArticleId></ArticleIdList></Reference><Reference><Citation>Darzynkiewicz E., Stepinski J., Ekiel I., Jin Y., Haber D., Sijuwade T., Tahara S. Beta-globin mRNAs capped with m7G, m22.7G or m32.2.7G differ in intrinsic translation efficiency. Nucleic Acids Res. 1988;16:8953–8962. doi: 10.1093/nar/16.18.8953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/16.18.8953</ArticleId><ArticleId IdType="pmc">PMC338645</ArticleId><ArticleId IdType="pubmed">3174438</ArticleId></ArticleIdList></Reference><Reference><Citation>Yisraeli J.K., Melton D.A. Synthesis of long, capped transcripts in vitro by SP6 and T7 RNA polymerases. Methods Enzymol. 1989;180:42–50. doi: 10.1016/0076-6879(89)80090-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0076-6879(89)80090-4</ArticleId><ArticleId IdType="pubmed">2559301</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman T.M. Superior 5′ homogeneity of RNA from ATP-initiated transcription under the T7 2.5 promoter. Nucleic Acids Res. 2004;32:14e. doi: 10.1093/nar/gnh007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gnh007</ArticleId><ArticleId IdType="pmc">PMC373309</ArticleId><ArticleId IdType="pubmed">14744982</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquinelli A.E., Dahlberg J.E., Lund E. Reverse 5′ caps in RNAs made in vitro by phage RNA polymerases. RNA. 1995;1:957–967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369344</ArticleId><ArticleId IdType="pubmed">8548660</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepinski J., Waddell C., Stolarski R., Darzynkiewicz E., Rhoads R.E. Synthesis and properties of mRNAs containing the novel “anti-reverse” cap analogs 7-methyl(3′-O-methyl)GpppG and 7-methyl (3′-deoxy)GpppG. RNA. 2001;7:1486–1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1370192</ArticleId><ArticleId IdType="pubmed">11680853</ArticleId></ArticleIdList></Reference><Reference><Citation>Jemielity J., Fowler T., Zuberek J., Stepinski J., Lewdorowicz M., Niedzwiecka A., Stolarski R., Darzynkiewicz E., Rhoads R.E. Novel “anti-reverse” cap analogs with superior translational properties. RNA. 2003;9:1108–1122. doi: 10.1261/rna.5430403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.5430403</ArticleId><ArticleId IdType="pmc">PMC1370475</ArticleId><ArticleId IdType="pubmed">12923259</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai A., Jankowska-Anyszka M., Centers A., Chlebicka L., Stepinski J., Stolarski R., Darzynkiewicz E., Rhoads R.E. Quantitative Assessment of mRNA Cap Analogues as Inhibitors of in Vitro Translation. Biochemistry. 1999;38:8538–8547. doi: 10.1021/bi9830213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi9830213</ArticleId><ArticleId IdType="pubmed">10387101</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuberek J., Wyslouch-Cieszynska A., Niedzwiecka A., Dadlez M., Stepinski J., Augustyniak W., Gingras A.-C., Zhang Z., Burley S.K., Sonenberg N., et al. Phosphorylation of eIF4E attenuates its interaction with mRNA cap analogs by electrostatic repulsion: Intein-mediated protein ligation strategy to obtain phosphorylated protein. RNA. 2003;9:52–61. doi: 10.1261/rna.2133403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.2133403</ArticleId><ArticleId IdType="pmc">PMC1370370</ArticleId><ArticleId IdType="pubmed">12554876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalska J., Lewdorowicz M., Zuberek J., Bojarska E., Wojcik J., Cohen L.S., Davis R.E., Stepinski J., Stolarski R., Darzynkiewicz E., et al. Synthesis and Properties of Mrna cap Analogs Containing Phosphorothioate Moiety In 5′,5′-Triphosphate Chain. Nucleosides Nucleotides Nucleic Acids. 2005;24:595–600. doi: 10.1081/NCN-200061915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1081/NCN-200061915</ArticleId><ArticleId IdType="pubmed">16247995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalska J., Lewdorowicz M., Zuberek J., Grudzien-Nogalska E., Bojarska E., Stepinski J., Rhoads R.E., Darzynkiewicz E., Davis R.E., Jemielity J. Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS. RNA. 2008;14:1119–1131. doi: 10.1261/rna.990208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.990208</ArticleId><ArticleId IdType="pmc">PMC2390807</ArticleId><ArticleId IdType="pubmed">18430890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalska J., Lukaszewicz M., Zuberek J., Darzynkiewicz E., Jemielity J. Phosphoroselenoate Dinucleotides for Modification of mRNA 5′ End. ChemBioChem. 2009;10:2469–2473. doi: 10.1002/cbic.200900522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.200900522</ArticleId><ArticleId IdType="pubmed">19739194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalska J., del Nogal A.W., Darzynkiewicz Z.M., Buck J., Nicola C., Kuhn A.N., Lukaszewicz M., Zuberek J., Strenkowska M., Ziemniak M., et al. Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: Versatile tools for manipulation of therapeutically relevant cap-dependent processes. Nucleic Acids Res. 2014;42:10245–10264. doi: 10.1093/nar/gku757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku757</ArticleId><ArticleId IdType="pmc">PMC4176373</ArticleId><ArticleId IdType="pubmed">25150148</ArticleId></ArticleIdList></Reference><Reference><Citation>Grudzien-Nogalska E., Jemielity J., Kowalska J., Darzynkiewicz E., Rhoads R.E. Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells. RNA. 2007;13:1745–1755. doi: 10.1261/rna.701307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.701307</ArticleId><ArticleId IdType="pmc">PMC1986804</ArticleId><ArticleId IdType="pubmed">17720878</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W., Slepenkov S., Grudzien-Nogalska E., Kowalska J., Kulis M., Zuberek J., Lukaszewicz M., Darzynkiewicz E., Jemielity J., Rhoads R.E. Translation, stability, and resistance to decapping of mRNAs containing caps substituted in the triphosphate chain with BH3, Se, and NH. RNA. 2011;17:978–988. doi: 10.1261/rna.2430711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.2430711</ArticleId><ArticleId IdType="pmc">PMC3078746</ArticleId><ArticleId IdType="pubmed">21447710</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalek M., Jemielity J., Darzynkiewicz Z.M., Bojarska E., Stepinski J., Stolarski R., Davis R.E., Darzynkiewicz E. Enzymatically stable 5′ mRNA cap analogs: Synthesis and binding studies with human DcpS decapping enzyme. Bioorganic Med. Chem. 2006;14:3223–3230. doi: 10.1016/j.bmc.2005.12.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2005.12.045</ArticleId><ArticleId IdType="pubmed">16431118</ArticleId></ArticleIdList></Reference><Reference><Citation>Grudzien E., Kalek M., Jemielity J., Darzynkiewicz E., Rhoads R.E. Differential Inhibition of mRNA Degradation Pathways by Novel Cap Analogs. J. Biol. Cgem. 2006;281:1857–1867. doi: 10.1074/jbc.M509121200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M509121200</ArticleId><ArticleId IdType="pubmed">16257956</ArticleId></ArticleIdList></Reference><Reference><Citation>Rydzik A.M., Lukaszewicz M., Zuberek J., Kowalska J., Darzynkiewicz Z.M., Darzynkiewicz E., Jemielity J. Synthetic dinucleotide mRNA cap analogs with tetraphosphate 5′,5′ bridge containing methylenebis(phosphonate) modification. Org. Biomol. Chem. 2009;7:4763–4776. doi: 10.1039/b911347a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b911347a</ArticleId><ArticleId IdType="pubmed">19865714</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziemniak M., Kowalska J., Lukaszewicz M., Zuberek J., Wnek K., Darzynkiewicz E., Jemielity J. Phosphate-modified analogues of m 7 GTP and m 7 Gppppm 7 G—Synthesis and biochemical properties. Bioorganic Med. Chem. 2015;23:5369–5381. doi: 10.1016/j.bmc.2015.07.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2015.07.052</ArticleId><ArticleId IdType="pubmed">26264844</ArticleId></ArticleIdList></Reference><Reference><Citation>Strenkowska M., Grzela R., Majewski M., Wnek K., Kowalska J., Lukaszewicz M., Zuberek J., Darzynkiewicz E., Kuhn A.N., Sahin U., et al. Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential. Nucleic Acids Res. 2016;44:9578–9590. doi: 10.1093/nar/gkw896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw896</ArticleId><ArticleId IdType="pmc">PMC5175369</ArticleId><ArticleId IdType="pubmed">27903882</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojtczak B.A., Sikorski P.J., Fac-Dabrowska K., Nowicka A., Warminski M., Kubacka D., Nowak E., Nowotny M., Kowalska J., Jemielity J. 5′-Phosphorothiolate Dinucleotide Cap Analogues: Reagents for Messenger RNA Modification and Potent Small-Molecular Inhibitors of Decapping Enzymes. J. Am. Chem. Soc. 2018;140:5987–5999. doi: 10.1021/jacs.8b02597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.8b02597</ArticleId><ArticleId IdType="pubmed">29676910</ArticleId></ArticleIdList></Reference><Reference><Citation>Walczak S., Nowicka A., Kubacka D., Fac K., Wanat P., Mroczek S., Kowalska J., Jemielity J. A novel route for preparing 5′ cap mimics and capped RNAs: Phosphate-modified cap analogues obtained via click chemistry. Chem. Sci. 2017;8:260–267. doi: 10.1039/C6SC02437H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6SC02437H</ArticleId><ArticleId IdType="pmc">PMC5355871</ArticleId><ArticleId IdType="pubmed">28451173</ArticleId></ArticleIdList></Reference><Reference><Citation>Walczak S., Sikorski P.J., Kasprzyk R., Kowalska J., Jemielity J. Exploring the potential of phosphotriazole 5′ mRNA cap analogues as efficient translation initiators. Org. Biomol. Chem. 2018;16:6741–6748. doi: 10.1039/C8OB01720D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8OB01720D</ArticleId><ArticleId IdType="pubmed">30187040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozarski M., Drazkowska K., Bednarczyk M., Warminski M., Jemielity J., Kowalska J. Towards superior mRNA caps accessible by click chemistry: Synthesis and translational properties of triazole-bearing oligonucleotide cap analogs. RSC Adv. 2023;13:12809–12824. doi: 10.1039/D3RA00026E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D3RA00026E</ArticleId><ArticleId IdType="pmc">PMC10126820</ArticleId><ArticleId IdType="pubmed">37114020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kore A.R., Shanmugasundaram M., Charles I., Cheng A.M., Barta T.J. Synthesis and application of 2′-fluoro-substituted cap analogs. Bioorganic Med. Chem. Lett. 2007;17:5295–5299. doi: 10.1016/j.bmcl.2007.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2007.08.029</ArticleId><ArticleId IdType="pmc">PMC2151044</ArticleId><ArticleId IdType="pubmed">17728131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kore A.R., Charles I. Synthesis and evaluation of 2′-O-allyl substituted dinucleotide cap analog for mRNA translation. Bioorganic Med. Chem. 2010;18:8061–8065. doi: 10.1016/j.bmc.2010.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2010.09.013</ArticleId><ArticleId IdType="pubmed">20943399</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugasundaram M., Charles I., Kore A.R. Design, synthesis and biological evaluation of dinucleotide mRNA cap analog containing propargyl moiety. Bioorganic Med. Chem. 2016;24:1204–1208. doi: 10.1016/j.bmc.2016.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2016.01.048</ArticleId><ArticleId IdType="pubmed">26899596</ArticleId></ArticleIdList></Reference><Reference><Citation>Senthilvelan A., Vonderfecht T., Shanmugasundaram M., Potter J., Kore A.R. Click-iT trinucleotide cap analog: Synthesis, mRNA translation, and detection. Bioorganic Med. Chem. 2023;77:117128. doi: 10.1016/j.bmc.2022.117128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2022.117128</ArticleId><ArticleId IdType="pubmed">36516685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kore A.R., Shanmugasundaram M., Vlassov A.V. Synthesis and application of a new 2′,3′-isopropylidene guanosine substituted cap analog. Bioorganic Med. Chem. Lett. 2008;18:4828–4832. doi: 10.1016/j.bmcl.2008.07.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2008.07.075</ArticleId><ArticleId IdType="pubmed">18684622</ArticleId></ArticleIdList></Reference><Reference><Citation>Warminski M., Kowalska J., Buck J., Zuberek J., Lukaszewicz M., Nicola C., Kuhn A.N., Sahin U., Darzynkiewicz E., Jemielity J. The synthesis of isopropylidene mRNA cap analogs modified with phosphorothioate moiety and their evaluation as promoters of mRNA translation. Bioorganic Med. Chem. Lett. 2013;23:3753–3758. doi: 10.1016/j.bmcl.2013.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2013.05.001</ArticleId><ArticleId IdType="pubmed">23726029</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziemniak M., Szabelski M., Lukaszewicz M., Nowicka A., Darzynkiewicz E., Rhoads R.E., Wieczorek Z., Jemielity J. Synthesis and evaluation of fluorescent cap analogues for mRNA labelling. RSC Adv. 2013;3:20943–20958. doi: 10.1039/c3ra42769b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c3ra42769b</ArticleId><ArticleId IdType="pmc">PMC3834968</ArticleId><ArticleId IdType="pubmed">24273643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kore A.R., Shanmugasundaram M., Charles I., Vlassov A.V., Barta T.J. Locked Nucleic Acid (LNA)-Modified Dinucleotide mRNA Cap Analogue: Synthesis, Enzymatic Incorporation, and Utilization. J. Am. Chem. Soc. 2009;131:6364–6365. doi: 10.1021/ja901655p.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja901655p</ArticleId><ArticleId IdType="pubmed">19385620</ArticleId></ArticleIdList></Reference><Reference><Citation>Senthilvelan A., Vonderfecht T., Shanmugasundaram M., Pal I., Potter J., Kore A.R. Trinucleotide Cap Analogue Bearing a Locked Nucleic Acid Moiety: Synthesis, mRNA Modification, and Translation for Therapeutic Applications. Org. Lett. 2021;23:4133–4136. doi: 10.1021/acs.orglett.1c01037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.orglett.1c01037</ArticleId><ArticleId IdType="pubmed">34008991</ArticleId></ArticleIdList></Reference><Reference><Citation>Jemielity J., Lukaszewicz M., Kowalska J., Czarnecki J., Zuberek J., Darzynkiewicz E. Synthesis of biotin labelled cap analogue–incorporable into mRNA transcripts and promoting cap-dependent translation. Org. Biomol. Chem. 2012;10:8570–8574. doi: 10.1039/c2ob26060c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c2ob26060c</ArticleId><ArticleId IdType="pubmed">22832840</ArticleId></ArticleIdList></Reference><Reference><Citation>Bednarek S., Madan V., Sikorski P.J., Bartenschlager R., Kowalska J., Jemielity J. mRNAs biotinylated within the 5′ cap and protected against decapping: New tools to capture RNA–protein complexes. Philos. Trans. R. Soc. B Biol. Sci. 2018;373:20180167. doi: 10.1098/rstb.2018.0167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2018.0167</ArticleId><ArticleId IdType="pmc">PMC6232584</ArticleId><ArticleId IdType="pubmed">30397103</ArticleId></ArticleIdList></Reference><Reference><Citation>Warminski M., Sikorski P.J., Warminska Z., Lukaszewicz M., Kropiwnicka A., Zuberek J., Darzynkiewicz E., Kowalska J., Jemielity J. Amino-Functionalized 5′ Cap Analogs as Tools for Site-Specific Sequence-Independent Labeling of mRNA. Bioconjugate Chem. 2017;28:1978–1992. doi: 10.1021/acs.bioconjchem.7b00291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.bioconjchem.7b00291</ArticleId><ArticleId IdType="pubmed">28613834</ArticleId></ArticleIdList></Reference><Reference><Citation>Warminski M., Grab K., Szczepanski K., Spiewla T., Zuberek J., Kowalska J., Jemielity J. Photoactivatable mRNA 5′ Cap Analogs for RNA-Protein Crosslinking. Adv. Sci. 2024:e2400994. doi: 10.1002/advs.202400994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.202400994</ArticleId><ArticleId IdType="pmc">PMC11423160</ArticleId><ArticleId IdType="pubmed">39049186</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamot A., Sikorski P.J., Warminski M., Kowalska J., Jemielity J. Azido-Functionalized 5′ Cap Analogues for the Preparation of Translationally Active mRNAs Suitable for Fluorescent Labeling in Living Cells. Angew. Chem. Int. Ed. 2017;56:15628–15632. doi: 10.1002/anie.201709052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201709052</ArticleId><ArticleId IdType="pubmed">29048718</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuo H., Li H., McGuire A.M., Fletcher C.M., Gingras A.-C., Sonenberg N., Wagner G. Structure of translation factor elF4E bound to m7GDP and interaction with 4E-binding protein. Nat. Struct. Mol. Biol. 1997;4:717–724. doi: 10.1038/nsb0997-717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsb0997-717</ArticleId><ArticleId IdType="pubmed">9302999</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcotrigiano J., Gingras A.-C., Sonenberg N., Burley S.K. Cocrystal Structure of the Messenger RNA 5′ Cap-Binding Protein (eIF4E) Bound to 7-methyl-GDP. Cell. 1997;89:951–961. doi: 10.1016/S0092-8674(00)80280-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80280-9</ArticleId><ArticleId IdType="pubmed">9200613</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedzwiecka A., Marcotrigiano J., Stepinski J., Jankowska-Anyszka M., Wyslouch-Cieszynska A., Dadlez M., Gingras A.-C., Mak P., Darzynkiewicz E., Sonenberg N., et al. Biophysical Studies of eIF4E Cap-binding Protein: Recognition of mRNA 5′ Cap Structure and Synthetic Fragments of eIF4G and 4E-BP1 Proteins. J. Mol. Biol. 2002;319:615–635. doi: 10.1016/S0022-2836(02)00328-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2836(02)00328-5</ArticleId><ArticleId IdType="pubmed">12054859</ArticleId></ArticleIdList></Reference><Reference><Citation>Grudzien E., Stepinski J., Jankowska-Anyszka M., Stolarski R., Darzynkiewicz E., Rhoads R.E. Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency. RNA. 2004;10:1479–1487. doi: 10.1261/rna.7380904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.7380904</ArticleId><ArticleId IdType="pmc">PMC1370634</ArticleId><ArticleId IdType="pubmed">15317978</ArticleId></ArticleIdList></Reference><Reference><Citation>Kore A.R., Xiao Z., Li M. Synthesis and biological validation of N7-(4-chlorophenoxyethyl) substituted dinucleotide cap analogs for mRNA translation. Bioorganic Med. Chem. 2013;21:4570–4574. doi: 10.1016/j.bmc.2013.05.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2013.05.041</ArticleId><ArticleId IdType="pubmed">23777824</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojcik R., Baranowski M.R., Markiewicz L., Kubacka D., Bednarczyk M., Baran N., Wojtczak A., Sikorski P.J., Zuberek J., Kowalska J., et al. Novel N7-Arylmethyl Substituted Dinucleotide mRNA 5′ cap Analogs: Synthesis and Evaluation as Modulators of Translation. Pharmaceutics. 2021;13:1941. doi: 10.3390/pharmaceutics13111941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics13111941</ArticleId><ArticleId IdType="pmc">PMC8623273</ArticleId><ArticleId IdType="pubmed">34834356</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Y., Chiu T.-L., Amin E.A., Polunovsky V., Bitterman P.B., Wagner C.R. Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP. Eur. J. Med. Chem. 2010;45:1304–1313. doi: 10.1016/j.ejmech.2009.11.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2009.11.054</ArticleId><ArticleId IdType="pmc">PMC2853597</ArticleId><ArticleId IdType="pubmed">20060622</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelissen N.V., Mineikaitė R., Erguven M., Muthmann N., Peters A., Bartels A., Rentmeister A. Post-synthetic benzylation of the mRNA 5′ cap via enzymatic cascade reactions. Chem. Sci. 2023;14:10962–10970. doi: 10.1039/D3SC03822J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D3SC03822J</ArticleId><ArticleId IdType="pmc">PMC10566477</ArticleId><ArticleId IdType="pubmed">37829022</ArticleId></ArticleIdList></Reference><Reference><Citation>Piecyk K., Davis R.E., Jankowska-Anyszka M. Synthesis of N2-modified 7-methylguanosine 5′-monophosphates as nematode translation inhibitors. Bioorganic Med. Chem. 2012;20:4781–4789. doi: 10.1016/j.bmc.2012.05.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2012.05.078</ArticleId><ArticleId IdType="pmc">PMC3636719</ArticleId><ArticleId IdType="pubmed">22748379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocmik I., Piecyk K., Rudzinska M., Niedzwiecka A., Darzynkiewicz E., Grzela R., Jankowska-Anyszka M. Modified ARCA analogs providing enhanced translational properties of capped mRNAs. Cell Cycle. 2018;17:1624–1636. doi: 10.1080/15384101.2018.1486164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2018.1486164</ArticleId><ArticleId IdType="pmc">PMC6133335</ArticleId><ArticleId IdType="pubmed">29954234</ArticleId></ArticleIdList></Reference><Reference><Citation>Piecyk K., Lukaszewicz M., Darzynkiewicz E., Jankowska-Anyszka M. Triazole-containing monophosphate mRNA cap analogs as effective translation inhibitors. RNA. 2014;20:1539–1547. doi: 10.1261/rna.046193.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.046193.114</ArticleId><ArticleId IdType="pmc">PMC4174436</ArticleId><ArticleId IdType="pubmed">25150228</ArticleId></ArticleIdList></Reference><Reference><Citation>Piecyk K., Lukaszewicz M., Kamel K., Janowska M., Pietrow P., Kmiecik S., Jankowska-Anyszka M. Isoxazole-containing 5′ mRNA cap analogues as inhibitors of the translation initiation process. Bioorganic Chem. 2020;96:103583. doi: 10.1016/j.bioorg.2020.103583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioorg.2020.103583</ArticleId><ArticleId IdType="pubmed">31972465</ArticleId></ArticleIdList></Reference><Reference><Citation>Grzela R., Piecyk K., Stankiewicz-Drogon A., Pietrow P., Lukaszewicz M., Kurpiejewski K., Darzynkiewicz E., Jankowska-Anyszka M. N2 modified dinucleotide cap analogs as a potent tool for mRNA engineering. RNA. 2023;29:200–216. doi: 10.1261/rna.079460.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.079460.122</ArticleId><ArticleId IdType="pmc">PMC9891257</ArticleId><ArticleId IdType="pubmed">36418172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurpiejewski K., Stankiewicz-Drogon A., Piecyk K., Rajkowska E., Skrzypczyk P., Geng J., Darzynkiewicz E., Grzela R., Jankowska-Anyszka M. The potential of N2-modified cap analogues for precise genetic manipulation through mRNA engineering. Front. Mol. Biosci. 2024;10:1269028. doi: 10.3389/fmolb.2023.1269028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2023.1269028</ArticleId><ArticleId IdType="pmc">PMC10878308</ArticleId><ArticleId IdType="pubmed">38380271</ArticleId></ArticleIdList></Reference><Reference><Citation>Klöcker N., Weissenboeck F.P., van Dülmen M., Špaček P., Hüwel S., Rentmeister A. Photocaged 5′ cap analogues for optical control of mRNA translation in cells. Nat. Chem. 2022;14:905–913. doi: 10.1038/s41557-022-00972-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41557-022-00972-7</ArticleId><ArticleId IdType="pmc">PMC7613264</ArticleId><ArticleId IdType="pubmed">35725774</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissenboeck F.P., Klöcker N., Špaček P., Hüwel S., Rentmeister A. Stabilized 5′ Cap Analogue for Optochemical Activation of mRNA Translation. ACS Omega. 2024;9:12810–12816. doi: 10.1021/acsomega.3c08505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.3c08505</ArticleId><ArticleId IdType="pmc">PMC10955689</ArticleId><ArticleId IdType="pubmed">38524462</ArticleId></ArticleIdList></Reference><Reference><Citation>Inagaki M., Abe N., Li Z., Nakashima Y., Acharyya S., Ogawa K., Kawaguchi D., Hiraoka H., Banno A., Meng Z., et al. Cap analogs with a hydrophobic photocleavable tag enable facile purification of fully capped mRNA with various cap structures. Nat. Commun. 2023;14:1–17. doi: 10.1038/s41467-023-38244-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38244-8</ArticleId><ArticleId IdType="pmc">PMC10175277</ArticleId><ArticleId IdType="pubmed">37169757</ArticleId></ArticleIdList></Reference><Reference><Citation>Anhäuser L., Klöcker N., Muttach F., Mäsing F., Špaček P., Studer A., Rentmeister A. A Benzophenone-Based Photocaging Strategy for the N7 Position of Guanosine. Angew. Chem. Int. Ed. 2019;59:3161–3165. doi: 10.1002/anie.201914573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201914573</ArticleId><ArticleId IdType="pmc">PMC7012642</ArticleId><ArticleId IdType="pubmed">31747109</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollu A., Schepers H., Klöcker N., Erguven M., Lawrence-Dörner A., Rentmeister A. Visible Light Activates Coumarin-Caged mRNA for Cytoplasmic Cap Methylation in Cells. Chem.–A Eur. J. 2023;30:e202303174. doi: 10.1002/chem.202303174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/chem.202303174</ArticleId><ArticleId IdType="pubmed">37883670</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojtczak B.A., Bednarczyk M., Sikorski P.J., Wojtczak A., Surynt P., Kowalska J., Jemielity J. Synthesis and Evaluation of Diguanosine Cap Analogs Modified at the C8-Position by Suzuki–Miyaura Cross-Coupling: Discovery of 7-Methylguanosine-Based Molecular Rotors. J. Org. Chem. 2023;88:6827–6846. doi: 10.1021/acs.joc.3c00126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.joc.3c00126</ArticleId><ArticleId IdType="pmc">PMC10242767</ArticleId><ArticleId IdType="pubmed">37209102</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyde J.L., Diamond M.S. Innate immune restriction and antagonism of viral RNA lacking 2′-O methylation. Virology. 2015;479-480:66–74. doi: 10.1016/j.virol.2015.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.01.019</ArticleId><ArticleId IdType="pmc">PMC4424151</ArticleId><ArticleId IdType="pubmed">25682435</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuberth-Wagner C., Ludwig J., Bruder A.K., Herzner A.-M., Zillinger T., Goldeck M., Schmidt T., Schmid-Burgk J.L., Kerber R., Wolter S., et al. A Conserved Histidine in the RNA Sensor RIG-I Controls Immune Tolerance to N1-2′O-Methylated Self RNA. Immunity. 2015;43:41–51. doi: 10.1016/j.immuni.2015.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.06.015</ArticleId><ArticleId IdType="pmc">PMC7128463</ArticleId><ArticleId IdType="pubmed">26187414</ArticleId></ArticleIdList></Reference><Reference><Citation>Despic V., Jaffrey S.R. mRNA ageing shapes the Cap2 methylome in mammalian mRNA. Nature. 2023;614:358–366. doi: 10.1038/s41586-022-05668-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05668-z</ArticleId><ArticleId IdType="pmc">PMC9891201</ArticleId><ArticleId IdType="pubmed">36725932</ArticleId></ArticleIdList></Reference><Reference><Citation>Drazkowska K., Tomecki R., Warminski M., Baran N., Cysewski D., Depaix A., Kasprzyk R., Kowalska J., Jemielity J., Sikorski P.J. 2′-O-Methylation of the second transcribed nucleotide within the mRNA 5′ cap impacts the protein production level in a cell-specific manner and contributes to RNA immune evasion. Nucleic Acids Res. 2022;50:9051–9071. doi: 10.1093/nar/gkac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac722</ArticleId><ArticleId IdType="pmc">PMC9458431</ArticleId><ArticleId IdType="pubmed">36018811</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson J.M., Ujita A., Hill E., Yousif-Rosales S., Smith C., Ko N., McReynolds T., Cabral C.R., Escamilla-Powers J.R., Houston M.E. Cap 1 Messenger RNA Synthesis with Co-transcriptional CleanCap® Analog by In Vitro Transcription. Curr. Protoc. 2021;1:e39. doi: 10.1002/cpz1.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpz1.39</ArticleId><ArticleId IdType="pubmed">33524237</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikorski P.J., Warminski M., Kubacka D., Ratajczak T., Nowis D., Kowalska J., Jemielity J. The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5′ cap modulates protein expression in living cells. Nucleic Acids Res. 2020;48:1607–1626. doi: 10.1093/nar/gkaa032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa032</ArticleId><ArticleId IdType="pmc">PMC7038993</ArticleId><ArticleId IdType="pubmed">31984425</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojtczak A., Kasprzyk R., Warmiński M., Ubych K., Kubacka D., Sikorski P.J., Jemielity J., Kowalska J. Evaluation of carboxyfluorescein-labeled 7-methylguanine nucleotides as probes for studying cap-binding proteins by fluorescence anisotropy. Sci. Rep. 2021;11:1–15. doi: 10.1038/s41598-021-87306-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-87306-8</ArticleId><ArticleId IdType="pmc">PMC8032668</ArticleId><ArticleId IdType="pubmed">33833335</ArticleId></ArticleIdList></Reference><Reference><Citation>Warminski M., Trepkowska E., Smietanski M., Sikorski P.J., Baranowski M.R., Bednarczyk M., Kedzierska H., Majewski B., Mamot A., Papiernik D., et al. Trinucleotide mRNA Cap Analogue N6-Benzylated at the Site of Posttranscriptional m6Am Mark Facilitates mRNA Purification and Confers Superior Translational Properties In Vitro and In Vivo. J. Am. Chem. Soc. 2024;146:8149–8163. doi: 10.1021/jacs.3c12629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.3c12629</ArticleId><ArticleId IdType="pmc">PMC10979456</ArticleId><ArticleId IdType="pubmed">38442005</ArticleId></ArticleIdList></Reference><Reference><Citation>Mlynarska-Cieslak A., Depaix A., Grudzien-Nogalska E., Sikorski P.J., Warminski M., Kiledjian M., Jemielity J., Kowalska J. Nicotinamide-Containing Di- and Trinucleotides as Chemical Tools for Studies of NAD-Capped RNAs. Org. Lett. 2018;20:7650–7655. doi: 10.1021/acs.orglett.8b03386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.orglett.8b03386</ArticleId><ArticleId IdType="pubmed">30479128</ArticleId></ArticleIdList></Reference><Reference><Citation>Depaix A., Grudzien-Nogalska E., Fedorczyk B., Kiledjian M., Jemielity J., Kowalska J. Preparation of RNAs with non-canonical 5′ ends using novel di- and trinucleotide reagents for co-transcriptional capping. Front. Mol. Biosci. 2022;9:854170. doi: 10.3389/fmolb.2022.854170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.854170</ArticleId><ArticleId IdType="pmc">PMC9437278</ArticleId><ArticleId IdType="pubmed">36060251</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber F., Motzkus N.A., Brandl L., Möhler M., Alempijevic A., Jäschke A. Identification and in vitro characterization of UDP-GlcNAc-RNA cap-modifying and decapping enzymes. Nucleic Acids Res. 2024;52:5438–5450. doi: 10.1093/nar/gkae353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkae353</ArticleId><ArticleId IdType="pmc">PMC11162767</ArticleId><ArticleId IdType="pubmed">38716860</ArticleId></ArticleIdList></Reference><Reference><Citation>McLennan A.G. The Nudix hydrolase superfamily. Cell. Mol. Life Sci. 2006;63:123–143. doi: 10.1007/s00018-005-5386-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-005-5386-7</ArticleId><ArticleId IdType="pmc">PMC11136074</ArticleId><ArticleId IdType="pubmed">16378245</ArticleId></ArticleIdList></Reference><Reference><Citation>McLennan A.G. Substrate ambiguity among the nudix hydrolases: Biologically significant, evolutionary remnant, or both? Cell. Mol. Life Sci. 2013;70:373–385. doi: 10.1007/s00018-012-1210-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-012-1210-3</ArticleId><ArticleId IdType="pmc">PMC11113851</ArticleId><ArticleId IdType="pubmed">23184251</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessman M.J., Frick D.N., O’Handley S.F. The MutT Proteins or “Nudix” Hydrolases, a Family of Versatile, Widely Distributed, “Housecleaning” Enzymes. J. Biol. Chem. 1996;271:25059–25062. doi: 10.1074/jbc.271.41.25059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.41.25059</ArticleId><ArticleId IdType="pubmed">8810257</ArticleId></ArticleIdList></Reference><Reference><Citation>Mildvan A., Xia Z., Azurmendi H., Saraswat V., Legler P., Massiah M., Gabelli S., Bianchet M., Kang L.-W., Amzel L. Structures and mechanisms of Nudix hydrolases. Arch. Biochem. Biophys. 2005;433:129–143. doi: 10.1016/j.abb.2004.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2004.08.017</ArticleId><ArticleId IdType="pubmed">15581572</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T., Yamagata Y. Visualization of mutagenic nucleotide processing by Escherichia coli MutT, a Nudix hydrolase. Proc. Natl. Acad. Sci. USA. 2022;119:e2203118119. doi: 10.1073/pnas.2203118119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2203118119</ArticleId><ArticleId IdType="pmc">PMC9173781</ArticleId><ArticleId IdType="pubmed">35594391</ArticleId></ArticleIdList></Reference><Reference><Citation>Song M.-G., Bail S., Kiledjian M. Multiple Nudix family proteins possess mRNA decapping activity. RNA. 2013;19:390–399. doi: 10.1261/rna.037309.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.037309.112</ArticleId><ArticleId IdType="pmc">PMC3677249</ArticleId><ArticleId IdType="pubmed">23353937</ArticleId></ArticleIdList></Reference><Reference><Citation>Grudzien-Nogalska E., Kiledjian M. New insights into decapping enzymes and selective mRNA decay. Wiley Interdiscip. Rev. RNA. 2016;8:e1379. doi: 10.1002/wrna.1379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1379</ArticleId><ArticleId IdType="pmc">PMC5179306</ArticleId><ArticleId IdType="pubmed">27425147</ArticleId></ArticleIdList></Reference><Reference><Citation>Grudzien-Nogalska E., Jiao X., Song M.-G., Hart R.P., Kiledjian M. Nudt3 is an mRNA decapping enzyme that modulates cell migration. RNA. 2016;22:773–781. doi: 10.1261/rna.055699.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.055699.115</ArticleId><ArticleId IdType="pmc">PMC4836651</ArticleId><ArticleId IdType="pubmed">26932476</ArticleId></ArticleIdList></Reference><Reference><Citation>Song M.-G., Li Y., Kiledjian M. Multiple mRNA Decapping Enzymes in Mammalian Cells. Mol. Cell. 2010;40:423–432. doi: 10.1016/j.molcel.2010.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.10.010</ArticleId><ArticleId IdType="pmc">PMC2982215</ArticleId><ArticleId IdType="pubmed">21070968</ArticleId></ArticleIdList></Reference><Reference><Citation>Grzela R., Nasilowska K., Lukaszewicz M., Tyras M., Stepinski J., Jankowska-Anyszka M., Bojarska E., Darzynkiewicz E., Grzela R., Nasilowska K., et al. Hydrolytic activity of human Nudt16 enzyme on dinucleotide cap analogs and short capped oligonucleotides. RNA. 2018;24:633–642. doi: 10.1261/rna.065698.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.065698.118</ArticleId><ArticleId IdType="pmc">PMC5900562</ArticleId><ArticleId IdType="pubmed">29483298</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojtczak B.A., Warminski M., Kowalska J., Lukaszewicz M., Honcharenko M., Smith C.I.E., Strömberg R., Darzynkiewicz E., Jemielity J. Clickable trimethylguanosine cap analogs modified within the triphosphate bridge: Synthesis, conjugation to RNA and susceptibility to degradation. RSC Adv. 2016;6:8317–8328. doi: 10.1039/C5RA25684D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5RA25684D</ArticleId></ArticleIdList></Reference><Reference><Citation>Garneau N.L., Wilusz J., Wilusz C.J. The highways and byways of mRNA decay. Nat. Rev. Mol. Cell Biol. 2007;8:113–126. doi: 10.1038/nrm2104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2104</ArticleId><ArticleId IdType="pubmed">17245413</ArticleId></ArticleIdList></Reference><Reference><Citation>Floor S.N., Jones B.N., Hernandez G.A., Gross J.D. A split active site couples cap recognition by Dcp2 to activation. Nat. Struct. Mol. Biol. 2010;17:1096–1101. doi: 10.1038/nsmb.1879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1879</ArticleId><ArticleId IdType="pmc">PMC2933276</ArticleId><ArticleId IdType="pubmed">20711189</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai T., Cho H., Liu Z., Bowler M.W., Piao S., Parker R., Kim Y.K., Song H. Structural Basis of the PNRC2-Mediated Link between mRNA Surveillance and Decapping. Structure. 2012;20:2025–2037. doi: 10.1016/j.str.2012.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2012.09.009</ArticleId><ArticleId IdType="pubmed">23085078</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Song M., Kiledjian M. Differential utilization of decapping enzymes in mammalian mRNA decay pathways. RNA. 2011;17:419–428. doi: 10.1261/rna.2439811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.2439811</ArticleId><ArticleId IdType="pmc">PMC3039142</ArticleId><ArticleId IdType="pubmed">21224379</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Dai J., Song M., Fitzgerald-Bocarsly P., Kiledjian M. Dcp2 Decapping Protein Modulates mRNA Stability of the Critical Interferon Regulatory Factor (IRF) IRF-7. Mol. Cell. Biol. 2012;32:1164–1172. doi: 10.1128/MCB.06328-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.06328-11</ArticleId><ArticleId IdType="pmc">PMC3295002</ArticleId><ArticleId IdType="pubmed">22252322</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulias K., Toczydłowska-Socha D., Hawley B.R., Liberman N., Takashima K., Zaccara S., Guez T., Vasseur J.-J., Debart F., Aravind L., et al. Identification of the m6Am Methyltransferase PCIF1 Reveals the Location and Functions of m6Am in the Transcriptome. Mol. Cell. 2019;75:631–643.e8. doi: 10.1016/j.molcel.2019.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.06.006</ArticleId><ArticleId IdType="pmc">PMC6703822</ArticleId><ArticleId IdType="pubmed">31279658</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G., Zhang J., Li Y., Li Z., Zhang N., Xu X., Wang T., Guan Z., Gao G.F., Yan J. hNUDT16: A universal decapping enzyme for small nucleolar RNA and cytoplasmic mRNA. Protein Cell. 2011;2:64–73. doi: 10.1007/s13238-011-1009-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1009-2</ArticleId><ArticleId IdType="pmc">PMC4875290</ArticleId><ArticleId IdType="pubmed">21337011</ArticleId></ArticleIdList></Reference><Reference><Citation>Zytek M., Kowalska J., Lukaszewicz M., Wojtczak B.A., Zuberek J., Ferenc-Mrozek A., Darzynkiewicz E., Niedzwiecka A., Jemielity J. Towards novel efficient and stable nuclear import signals: Synthesis and properties of trimethylguanosine cap analogs modified within the 5′,5′-triphosphate bridge. Org. Biomol. Chem. 2014;12:9184–9199. doi: 10.1039/C4OB01579G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4OB01579G</ArticleId><ArticleId IdType="pubmed">25296894</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukaszewicz M., Ferenc-Mrozek A., Bojarska E., Stelmach J., Stepinski J., Darzynkiewicz E. Contribution of Nudt12 enzyme to differentially methylated dinucleotides of 5′RNA cap structure. Biochim. Biophys. Acta (BBA) Gen. Subj. 2023;1867:130400. doi: 10.1016/j.bbagen.2023.130400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2023.130400</ArticleId><ArticleId IdType="pubmed">37301333</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrabąszczewska M., Winiewska-Szajewska M., Ostrowska N., Bojarska E., Stępiński J., Mancewicz Ł., Łukaszewicz M., Trylska J., Taube M., Kozak M., et al. Insight into the Binding and Hydrolytic Preferences of hNudt16 Based on Nucleotide Diphosphate Substrates. Int. J. Mol. Sci. 2021;22:10929. doi: 10.3390/ijms222010929.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222010929</ArticleId><ArticleId IdType="pmc">PMC8535469</ArticleId><ArticleId IdType="pubmed">34681586</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S., Grudzien-Nogalska E., Hamilton K., Jiao X., Yang J., Tong L., Kiledjian M. Mammalian Nudix proteins cleave nucleotide metabolite caps on RNAs. Nucleic Acids Res. 2020;48:6788–6798. doi: 10.1093/nar/gkaa402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa402</ArticleId><ArticleId IdType="pmc">PMC7337524</ArticleId><ArticleId IdType="pubmed">32432673</ArticleId></ArticleIdList></Reference><Reference><Citation>Grudzien-Nogalska E., Wu Y., Jiao X., Cui H., Mateyak M.K., Hart R.P., Tong L., Kiledjian M. Structural and mechanistic basis of mammalian Nudt12 RNA deNADding. Nat. Chem. Biol. 2019;15:575–582. doi: 10.1038/s41589-019-0293-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41589-019-0293-7</ArticleId><ArticleId IdType="pmc">PMC6527130</ArticleId><ArticleId IdType="pubmed">31101919</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., Li L., Chen K.-M., Homolka D., Gos P., Fleury-Olela F., McCarthy A.A., Pillai R.S. Decapping Enzyme NUDT12 Partners with BLMH for Cytoplasmic Surveillance of NAD-Capped RNAs. Cell Rep. 2019;29:4422–4434.e13. doi: 10.1016/j.celrep.2019.11.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.11.108</ArticleId><ArticleId IdType="pubmed">31875550</ArticleId></ArticleIdList></Reference><Reference><Citation>Laudenbach B.T., Krey K., Emslander Q., Andersen L.L., Reim A., Scaturro P., Mundigl S., Dächert C., Manske K., Moser M., et al. NUDT2 initiates viral RNA degradation by removal of 5′-phosphates. Nat. Commun. 2021;12:1–13. doi: 10.1038/s41467-021-27239-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27239-y</ArticleId><ArticleId IdType="pmc">PMC8616924</ArticleId><ArticleId IdType="pubmed">34824277</ArticleId></ArticleIdList></Reference><Reference><Citation>Rydzik A.M., Warminski M., Sikorski P.J., Baranowski M.R., Walczak S., Kowalska J., Zuberek J., Lukaszewicz M., Nowak E., Claridge T.D.W., et al. mRNA cap analogues substituted in the tetraphosphate chain with CX2: Identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation. Nucleic Acids Res. 2017;45:8661–8675. doi: 10.1093/nar/gkx569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx569</ArticleId><ArticleId IdType="pmc">PMC5587727</ArticleId><ArticleId IdType="pubmed">28666355</ArticleId></ArticleIdList></Reference><Reference><Citation>Page B.D.G., Valerie N.C.K., Wright R.H.G., Wallner O., Isaksson R., Carter M., Rudd S.G., Loseva O., Jemth A.-S., Almlöf I., et al. Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells. Nat. Commun. 2018;9:250. doi: 10.1038/s41467-017-02293-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02293-7</ArticleId><ArticleId IdType="pmc">PMC5772648</ArticleId><ArticleId IdType="pubmed">29343827</ArticleId></ArticleIdList></Reference><Reference><Citation>Mititelu M.-B., Hudeček O., Gozdek A., Benoni R., Nešuta O., Krasnodębski S., Kufel J., Cahová H. Arabidopsis thaliana NudiXes have RNA-decapping activity. RSC Chem. Biol. 2023;4:223–228. doi: 10.1039/D2CB00213B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2CB00213B</ArticleId><ArticleId IdType="pmc">PMC9994101</ArticleId><ArticleId IdType="pubmed">36908703</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer S., McLennan A.G. The complex enzymology of mRNA decapping: Enzymes of four classes cleave pyrophosphate bonds. Wiley Interdiscip. Rev. RNA. 2018;10:e1511. doi: 10.1002/wrna.1511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1511</ArticleId><ArticleId IdType="pubmed">30345629</ArticleId></ArticleIdList></Reference><Reference><Citation>Deana A., Celesnik H., Belasco J.G. The bacterial enzyme RppH triggers messenger RNA degradation by 5′ pyrophosphate removal. Nature. 2008;451:355–358. doi: 10.1038/nature06475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06475</ArticleId><ArticleId IdType="pubmed">18202662</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahová H., Winz M.-L., Höfer K., Nübel G., Jäschke A. NAD captureSeq indicates NAD as a bacterial cap for a subset of regulatory RNAs. Nature. 2015;519:374–377. doi: 10.1038/nature14020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14020</ArticleId><ArticleId IdType="pubmed">25533955</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao X., Chang J.H., Kilic T., Tong L., Kiledjian M. A Mammalian Pre-mRNA 5′ End Capping Quality Control Mechanism and an Unexpected Link of Capping to Pre-mRNA Processing. Mol. Cell. 2013;50:104–115. doi: 10.1016/j.molcel.2013.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.02.017</ArticleId><ArticleId IdType="pmc">PMC3630477</ArticleId><ArticleId IdType="pubmed">23523372</ArticleId></ArticleIdList></Reference><Reference><Citation>Picard-Jean F., Brand C., Tremblay-Létourneau M., Allaire A., Beaudoin M.C., Boudreault S., Duval C., Rainville-Sirois J., Robert F., Pelletier J., et al. 2′-O-methylation of the mRNA cap protects RNAs from decapping and degradation by DXO. PLoS ONE. 2018;13:e0193804. doi: 10.1371/journal.pone.0193804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0193804</ArticleId><ArticleId IdType="pmc">PMC5877831</ArticleId><ArticleId IdType="pubmed">29601584</ArticleId></ArticleIdList></Reference><Reference><Citation>Doamekpor S.K., Grudzien-Nogalska E., Mlynarska-Cieslak A., Kowalska J., Kiledjian M., Tong L. DXO/Rai1 enzymes remove 5′-end FAD and dephospho-CoA caps on RNAs. Nucleic Acids Res. 2020;48:6136–6148. doi: 10.1093/nar/gkaa297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa297</ArticleId><ArticleId IdType="pmc">PMC7293010</ArticleId><ArticleId IdType="pubmed">32374864</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.-T., Bercovich N., Loh B., Jonas S., Izaurralde E. The activation of the decapping enzyme DCP2 by DCP1 occurs on the EDC4 scaffold and involves a conserved loop in DCP1. Nucleic Acids Res. 2014;42:5217–5233. doi: 10.1093/nar/gku129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku129</ArticleId><ArticleId IdType="pmc">PMC4005699</ArticleId><ArticleId IdType="pubmed">24510189</ArticleId></ArticleIdList></Reference><Reference><Citation>Borbolis F., Syntichaki P. Biological implications of decapping: Beyond bulk mRNA decay. FEBS J. 2021;289:1457–1475. doi: 10.1111/febs.15798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15798</ArticleId><ArticleId IdType="pubmed">33660392</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y., Schofield J.A., Simon M.D., Slavoff S.A. Global Profiling of Cellular Substrates of Human Dcp2. Biochemistry. 2020;59:4176–4188. doi: 10.1021/acs.biochem.0c00069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.0c00069</ArticleId><ArticleId IdType="pmc">PMC7641959</ArticleId><ArticleId IdType="pubmed">32365300</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y., Schofield J.A., Na Z., Hann T., Simon M.D., Slavoff S.A. Discovery of cellular substrates of human RNA-decapping enzyme DCP2 using a stapled bicyclic peptide inhibitor. Cell Chem. Biol. 2020;28:463–474.e7. doi: 10.1016/j.chembiol.2020.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2020.12.003</ArticleId><ArticleId IdType="pmc">PMC8052284</ArticleId><ArticleId IdType="pubmed">33357462</ArticleId></ArticleIdList></Reference><Reference><Citation>Vvedenskaya I.O., Nickels B.E. CapZyme-Seq: A 5′-RNA-Seq Method for Differential Detection and Quantitation of NAD-Capped and Uncapped 5′-Triphosphate RNA. STAR Protoc. 2020;1:100002. doi: 10.1016/j.xpro.2019.100002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2019.100002</ArticleId><ArticleId IdType="pmc">PMC7384699</ArticleId><ArticleId IdType="pubmed">32719830</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>